°Q½×°Ï>ªYÄ£¥ÍÂå
¥«³õ­º¨£·sÃÄ ±ÂÅv½Í¤¤
·|­û:hung1201 10149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
¥«³õ­º¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009

6634 ªYÄ£

ªÑ¥»: 3.832»õ

¥D­n·~°È:

¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo

¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤)

¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤)

Ä~Äò©¹¤U¬Ý...!

=============================================================================

²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ)

¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ«

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.µL¦w¥þ©Ê°ÝÃD

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x

¬ãµo¶¥¬q:

1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á

2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ

Àø®Ä¤ÀªR¡G

1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n

2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009)

=============================================================================

²£«~02¡GSNP-630

¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE)

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡

4.µL¦w¥þ©Ê°ÝÃD

¬ãµo¶¥¬q:

1.Á{§É«e

2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C

3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C

Àø®Ä¤ÀªR¡G

1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05

=============================================================================

²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯)

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯)

²£«~Àu¶Õ:

1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê

2.¸Ñ¨M­¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs)

3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«

2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^

3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O

¬ãµo¶¥¬q:

1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç

2.¤w¥Ó½ÐUSFDA¼Ï&#32445;Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D

3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç

=============================================================================

²£«~04¡GSNP-830/ SNP-840

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B­««×¯kµh)

²£«~Àu¶Õ:

1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è

2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è

2.½Æ¤è¤w¥Ñ¬ü°êFDA­n¨D­°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä

3.¦³¨Ï¥Î±M§Q¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y

4.¥i¼W¥[¤AñQÓi×ô¾¯¶q

¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A­°§C¦¨Å}°Æ§@¥Î

5.¤GªÌ¾Ü¤@±ÂÅv

6.¥i¼W¥[¥«¦û²v

¬ãµo¶¥¬q:

1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç

SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ý­n¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç

µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ

=============================================================================

*****************************************************************************

SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G

1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

=============================================================================

*****************************************************************************

¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G

1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv

3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿­±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

=============================================================================

*****************************************************************************

¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@­p¹º

§Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó

¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ù­È±o´Á«Ý¡A¦³¾÷·|¬O ¤U¤@­Ó ¦X¤@ ÄƪÑ

-----------------------------------------------------------------------------

¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×)

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/15 ¤U¤È 10:10:46²Ä2725½g¦^À³
J&J»¡:development of alternative analgesics constitutes a perseverant unmet need.

ªYÄ£:¸ÑÂê40¦~¨x¬r©Ê°ÝÃD(¯àªA¥Î§ó°ªªº¾¯¶q»Pªø®É¶¡ªA¥Î)

±ÂÅv¾÷²v?

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/11/27 ¤W¤È 11:12:21²Ä 2686 ½g¦^À³

2022.8¤ë-J&J¶}µoªºµL¨x¬rTylenol(JNJ-10450232)¬ã¨s³ø§i

www.sciencedirect.com/science/article/abs/pii/S0273230022001234

...¦pªG«ö·Ó²£«~¼ÐÅÒªº«ü¥Ü¨Ï¥Î¹ï¤A酰®ò°ò×ô¡]¼³¼ö®§µh¡^¡B¥¬¬¥ªâ¡B萘´¶¥Í¡BÂù´âªâ»Ä©Mªü¥q¤ÇªL¬O¦³®Ä¥B¦w¥þªº¡A¦ý¦pªG¥H°ª©ó±ÀÂ˪º¾¯¶q©M/©Î§óªøªº«ùÄò®É¶¡ÀݥΥ¦­Ì¡A«h¤£¨}¤ÏÀ³ªº­·ÀI·|¼W¥[¡C¦]¦¹¡A[´À¥NÂíµhÃĪº¶}µoºc¦¨¤F¤@­Óªø´Á¥¼º¡¨¬ªº»Ý¨D¡C]

·|­û:dk10140377µoªí®É¶¡:2022/12/15 ¤U¤È 02:16:07²Ä2724½g¦^À³
ÁÙ¦³¤@¨Ç¥x¤¤¥J¤]¦b½æ¡A§Æ±æ¤£¬O¤ºÀ`¥ý¥X²æ

³Ì¦nªº¼@¥»¬O¦b¦~©³¦X§@±ÂÅv¦¨¥\¡A©ú¦~3¤ë«e¤W¤£¤W´N¤£­«­n¤F¡C

¾Ç¤@¤U±Ó¦¨öt­Ó70%

·|­û:¾¾¹À©OÎN¹À«¡10150521µoªí®É¶¡:2022/12/14 ¤U¤È 06:14:15²Ä2723½g¦^À³
¸s¯qª÷¹©--¥ÁÅv¤µ¤Ñ½æ38±i¡A¤w³sÄò¥|¤Ñ½æ¶W¦@146±i¡C
·|­û:½²ºû¤¯10143700µoªí®É¶¡:2022/12/14 ¤U¤È 02:59:38²Ä2722½g¦^À³
«e­±¦³Åª¨ì¤½¥q¥ý¥H§C¬r©Ê¥Ó½Ð¦A¹F¨ìµL¬r©Ê´«ÃÒ¡AµL¬r©Ê¦ü¥G¨BÆJ¸û¦h¸û¤£®e©ö¹F¦¨¡C
·|­û:ROGER588910148151µoªí®É¶¡:2022/12/14 ¤U¤È 12:38:57²Ä2721½g¦^À³
Q:¬°¦ó²Ä¤@®aÃļt¶i¦æÀø®ÄÅçÃÒ¡Aµo²{ÅçÃÒµ²ªG¤£¦p¹w´Á?µM«áªYÄ£­«·s½Õ¾ã¨º¨ÇÅçÃÒ±ø¥ó?

¨ú±o²Ä¤T¤èÅçÃÒ³æ¦ì¥¿¦¡¸ÕÅç³ø§i¡AÃÒ¹êSNP-810µL¨x¬r©Ê¡C

ªYÄ£¨S¸Ô»¡¡A¤]¨S¤H¸ß°Ý¤½¥q?¶K½g¬ü°ê¦P¦æµoªí¬ã¨s½×¤å¡A¦³¿³½ìªÌ¦Û¦æ±ÀºV«ä¦Ò¡C

2021.9.30 ¨Ï¥Î¹ï¤A酰®ò°ò×ô¨x¬r©Ê¼Ò«¬¶i¦æ¾÷²z¬ã¨sªº«Øij¥H¤Î¦p¦óÁקK±`¨£ªº³´¨À

www.sciencedirect.com/science/article/pii/S2211383521003828

¨Ï¥Î APAP ¨x¬r©Ê¼Ò«¬®É³Ì±`¥Çªº¿ù»~

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/14 ¤W¤È 10:51:57²Ä2720½g¦^À³
¬ü°ê¥tÃþ¾~¤ù¾Ôª§¡A¤£¥uÃļt½ß¨ì²æ¿Ç¤l¡A3®a³sÂêÃħ½³q¸ô¤]­n¸ò½ß131»õ¬ü¤¸!

abcnews.go.com/Health/wireStory/cvs-walgreens-finalize-10b-settlements-opioids-95090148

CVS ©M Walgreens ¤w¦P·N¦V¦{©M¦a¤è¬F©²¤ä¥IÁ`­p¶W¹L 100 »õ¬ü¤¸ªº¶O¥Î¡A¥H¤Fµ²¦³Ãöªü¤ùÃþÃĪ«¦¬¶Oªº¶D³^¡A²{¦b·Qª¾¹D¦U¦{¬O§_·|¦b 12 ¤ë 31 ¤é¤§«e±µ¨ü³o¨Ç¥æ©ö¡C

³o¨Ç¥æ©ö¬Oªñ¦~¨ÓÀÀij©M³Ì²×¹F¦¨ªºªü¤ùÃþÃĪ«©M¸Ñ®ö¼é¤¤³W¼Ò³Ì¤jªº¤@µ§¡AÁ`ÃB¶W¹L 500 »õ¬ü¤¸¡C¥t¤@®a¤j«¬ÃĩйBÀç°Ó¨Uº¸º¿¤W­Ó¤ë¤]¦P·N¥H 31 »õ¬ü¤¸¹F¦¨©M¸Ñ

·|­û:Rock00910149258µoªí®É¶¡:2022/12/14 ¤W¤È 10:08:18²Ä2719½g¦^À³
¤§«eRoger¤j¦³¶K¤W­J³Õ¤hªººtÁ¿¼v¤ù

Ãö©ó±ÂÅv¦X¬ù¤º®e¬O¦r¦r­p¸û¨ì»P·|¤H­û³£­nñ¦b¦X¬ù¸Ì

ÁקK¥¼¨Ó³Q¥t¥~¶}µo¡A¨ì®É¯uªº·|±ý­úµL²\

IPO©µ´Á´N©µ´Á§a¡I¦X¬ù½Í¦n¤ñ¸û­«­n¡C

·|­û:¤p¨k¤H10151116µoªí®É¶¡:2022/12/14 ¤W¤È 09:16:04²Ä2718½g¦^À³
¤£¥²¬°¤F IPO ®Éµ{¥h§´¨ó±ÂÅv±ø¥ó¡A³o¬O¥»¾¥­Ë¸m¡C(+1)

================================

¦P·N¡A¦³¹w·PÁÙ¯uªº·|©µ´Á

·|­û:dk10140377µoªí®É¶¡:2022/12/13 ¤U¤È 10:41:59²Ä2717½g¦^À³
¤£¥²¬°¤F IPO ®Éµ{¥h§´¨ó±ÂÅv±ø¥ó¡A³o¬O¥»¾¥­Ë¸m¡C(+1)

=================================================

«D±`¦P·N¡A¦ý¸U¤@©µ´Á®ø®§¤@¥X¨Ó¡A¿³¶Q¤j«ã¯«´N¦nª±¤F!!µ¹¥D¤O¤W¨® ¤W¤U¨ä¤âªº¾÷·|

¤]µ¹¤pªÑ¥Á¾ß«K©yªº¾÷·|

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/13 ¤U¤È 05:37:42²Ä2716½g¦^À³
¤£¥²¬°¤F IPO ®Éµ{¥h§´¨ó±ÂÅv±ø¥ó¡A³o¬O¥»¾¥­Ë¸m¡C(+1)

·~¬ÉªºÁn­µ¡A¨S¤J¥DºÞªº¦Õ!

2017.10.16--¥Í§Þ¥H¬ì§Þ¨Æ·~¥Ó½Ð¤WÂd ²£©x¾ÇÆ~©µªø®Ö­ã¨ç®Ä´Á

www.chinatimes.com/newspapers/20171016000145-260210?chdtv

³Í°òÃҨ鸳¨Æªø³\¹D¸q¡G...³\¹D¸q»{¬°©Ó¾P°Ó§@²Ä1¼h§âÃö¡A¨ú±o¥­¿ÅÂI¡A¥H¬ì§Þ¨Æ·~¤¤IC¥b¾ÉÅé²£·~®É¶¡¸ûµu¡A¦]¦¹¨ú±o¤u·~§½®Ö­ã¨çªº1¦~´Á­­ÁÙ¥i¥H¡A¦ý¥Í§Þ·sÃĬãµo¤£¬O1¦~´N¥i¥H¬Ý¥X¦¨ªG¡A®É¶¡¸û¬°º©ªø¡A¥Í§Þ²£·~ªº®É¶¡¥i¥H©µªø¬°1¦~¥b©Î¨â¦~¡F

---------------------------------------------------------------------------------------------------

·|­û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/9/13 ¤U¤È 04:01:08²Ä 2454 ½g¦^À³

­J SIR »¡¹L¡A±ÂÅv½Í§P¹Lµ{­n«ÜÄYÂÔ¥B¯Ó®É¡A¦X¬ù¤å¦r¤Wªº¥[µù»P­­¨î¥²¶·­n¨ì¦ì¡C

­Y¤½¥q±ÂÅv¤§«á¤~¨««áÄò IPO ¬yµ{ªº¸Ü¡A§Ú±À´ú¤µ¦~¥i¯à¤£·|¤W¥«¡AIPO ¥u¬O¹Lµ{¡A±ø¥ó½Íªº¦n¤~¬O­«ÂI¡A¤£¥²¬°¤F IPO ®Éµ{¥h§´¨ó±ÂÅv±ø¥ó¡A³o¬O¥»¾¥­Ë¸m¡C

---------------------------------------------------------------------------------------------------

·|­û¡GNtumgk10151447 µoªí®É¶¡:2022/9/14 ¤W¤È 04:26:46²Ä 2461 ½g¦^À³

To ½Ñ¦ì¤j¤j

®Ú¾Ú¤p§Ì©ó«e´X­Ó§«ô­P¹q¤½¥q¸ß°Ýªºµ²ªG¡A¤WÂd®Éµ{¦w±ÆÀ³¸Ó¬O·|¸¨¦b©ú¦~H1¡C

·|­û:dk10140377µoªí®É¶¡:2022/12/13 ¤U¤È 03:37:50²Ä2715½g¦^À³
°ò¥»­±§Ú·Q¦U¦ì¤j¤j³ÌÀ´¡A¥u¬O§Þ³N­±°¾®z¡A·íµM¬O¦Û¤wªº¬Ýªk°Õ¡C¤£¹L¬O¤£¬O¦¬¨ì¬ì§Þ¨ç¦h¤[¤º­n¤W¥«§r?·|¤£·|¹L´Á
·|­û:½²ºû¤¯10143700µoªí®É¶¡:2022/12/13 ¤U¤È 03:29:30²Ä2714½g¦^À³
dk¤j¤d¸U­n¦w¤ß¡AªYÄ£µ¹¥L©ñ2¦~¬Ý¬Ý¡A2¦~«áªº¤µ¤Ñ¬Ý·|¦h¤Ö¡H
·|­û:dk10140377µoªí®É¶¡:2022/12/13 ¤U¤È 03:08:27²Ä2713½g¦^À³
¤µ¤Ñ¯}110 ·Pı¤£¤Ó¦n
·|­û:½²ºû¤¯10143700µoªí®É¶¡:2022/12/12 ¤U¤È 02:06:11²Ä2712½g¦^À³
ªYÄ£¤½¥q§â¤îµh¾¯°µ¨ìµL¨x¡BµÇ¬r¡A±ÂÅv¦b±æ¡F­«¤ß©¹6¨t§V¤O¡A6¨t©ú«á2¦~¬O±ÂÅv¦¨¼ô´Á¡A³o³¡¤À¼ç¦b°Ó¾÷21¥ü¥x¹ô¬O¤îµh¾¯1¥üªº21­¿¡A2Áû¤@¨Ö±ÂÅv15»õ¬ü¤¸¥H¤W¡q¦³Á{§É«e7»õ¬ü¤¸«e¨Ò·í°Ñ¦Ò¡r¡C­Y¦b¥¼¨Ó2¦~¤¤¬Y¤@¤Ñ¶¯¶¯µo¥¬6¨t±ÂÅv®ø®§¡A¤j®a´Nµo¤j°]¤F¡I
·|­û:ROGER588910148151µoªí®É¶¡:2022/12/12 ¤W¤È 10:28:14²Ä2711½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/12/12 ¤W¤È 10:03:20²Ä 2709 ½g¦^À³

...¦]¬°¦b¤@¨Ç¬ã¨s¤¤¹v¦V RIPK3 ¤¶¾ÉªºÃa¦º©Ê­ä¤`¥i¦³®Ä¹w¨¾ [APAP]»¤¾Éªº«æ©Ê¨x°IºÜ

------------------------------------------------------------------------------------------------

SNP-810¬°µL¨x¬r©Ê¤îµh¬O¥H»Ã¯À§í¨î¾¯¨Ï[APAP]¬r©Ê¥NÁª«¤£¦A¥Í¦¨!

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/12 ¤W¤È 10:20:49²Ä2710½g¦^À³
RIPK3 ´`Àô¤ô¥­¤É°ª»P±wªÌ±q AD( «æ©Ê¥¢¥NÀv©Ê¨xµw¤Æ) ¶i®i¬° ACLF(ºC¥[«æ©Ê¨x°IºÜ)ªºÄY­«µ{«×©Mµu´Á¦º¤`²v¬ÛÃö!

F4(ÄY­«ÅÖºû¤Æ)---¥NÀv©Ê¨xµw¤Æ(SNP-610)»P¥¢¥NÀv©Ê¨xµw¤Æ¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/12/12 ¤W¤È 10:03:20²Ä 2709 ½g¦^À³

..¨ä¤¤ RIPK3 ´`Àô¤ô¥­¤É°ª»P±wªÌ±q AD ¶i®i¬° ACLF¡BACLF ªºÄY­«µ{«×©Mµu´Á¦º¤`²v¬ÛÃö¡Cºî¤W©Ò­z¡A¸Ó¬ã¨sªí©ú¡A´`Àô RIPK3 ¥i¯à§@¬°¤@ºØ¼ç¦bªº¥Íª«¼Ð»xª«¡A¥Î©ó¿ï¾Ü±wªÌ±µ¨ü°w¹ïRIPK1 ¤¶¾Éªº²Ó­M¦º¤`ªºÃĪ«ªvÀø¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/11/26 ¤U¤È 11:16:17²Ä 1488 ½g¦^À³

¡K.SNP-610´Á¤¤¤ÀªR¦³¨xŦÅÖºû±½´y»öFibroscan data¡AF4(ÄY­«ÅÖºû¤Æ)ªvÀø«e«á [¦³ÅãµÛ]®t²§¡C

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/12 ¤W¤È 10:03:20²Ä2709½g¦^À³
³Ìªñµoªíªº´X½g½×¤å¡A§ó¤ã¹ê¹v¦VCYP2E1ªºNASHªvÀø®ÄªG¡C

1. 2012.12.14-aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.26200

¬ã¨sªí©ú¡ACYP2E1 ¹ï RIPK3 ªºªí¹F°µ¥X¤F­«¤j°^Äm!

CYP2E1 ªº¯Ê¥¢°fÂà¤F¤A¾J¤¶¾Éªº RIPK3 ªí¹F¡A¦Ó RIPK3 ªº¯ÓºÜ¨Ã¥¼§ïÅܤA¾J³B²z»¤¾Éªº CYP2E1 ªí¹F¤É°ª¡Aªí©ú

CYP2E1 §@¬° RIPK3 ªº¤W´å°^ÄmªÌ¡C

2. 2022.6.23 -www.nature.com/articles/s41419-022-05009-y

¤HÃþ RIPK3 C¸­ÁC»Ä¤Æ¹ï©óÃa¦º«H¸¹¶Ç¾É¦ÜÃö­«­n

3. 2021.12.17 www.nature.com/articles/s41419-021-04442-9

³o¨Ç¼Æ¾Ú[­º¦¸ÃÒ©ú]¤F RIPK1 ¤¶¾Éªº²Ó­M¦º¤`¦b¤HÃþ©Mø¥¾¦°Êª« ACLF ¤¤ªº­«­n©Ê¡C

§Ú­Ì¤§«e´¿³ø¾É¹L ACLF ±wªÌµo¥Í«D­ä¤`©Ê²Ó­M¦º¤`ªº­«­n©Ê [ 9 ]¡CACLF ±wªÌ RIPK3 ´`Àô¤ô¥­ªºÅãµÛ¼W¥[¤ä«ù

RIPK1 ¤¶¾Éªº²Ó­M¦º¤`¥i¯à¬O¨ä§@¥Î¾÷¨îªºÆ[ÂI¡CRIPK3 »P RIPK1 ©M pMLKL ¤@°_¬OÃa¦º©Ê­ä¤`³~®|ªºÃöÁä²Õ¦¨³¡¤À¡C

­«­nªº¬O¡ARIPK3 ¤ô¥­»P¥þ¨­ª¢¯g¼Ð»xª«±K¤Á¬ÛÃö¡A³o¤w³QÃÒ©ú¬O ACLF µo®iªº®Ö¤ß¾÷¨î

¦]¬°¦b¤@¨Ç¬ã¨s¤¤¹v¦V RIPK3 ¤¶¾ÉªºÃa¦º©Ê­ä¤`¥i¦³®Ä¹w¨¾ APAP »¤¾Éªº«æ©Ê¨x°IºÜ¡A¦ý¦b¨ä¥L¥O¤H¾á¼~ªº¬O¡A¦b¤M¨§

²y³J¥Õ A (ConA) »¤¾Éªº¦Û¨­§K¬Ì©Ê¨xª¢¤¤¡ARIPK3 ¯Ê¥¢¨ã¦³«OÅ@§@¥Î¡A¦Ó RIPK1 §í¨î·|¥[¼@¯e¯f¡B¥[³t°Êª«¦º¤`¡A¨Ã

¥B»P¨x²Ó­M¦º¤`¼W¥[¦³Ãö¡C

³o¤@Æ[¹îµ²ªG±o¨ì¤F¨â­Ó±wªÌ¶¤¦C¼Æ¾Úªº¤ä«ù¡A¨ä¤¤ RIPK3 ´`Àô¤ô¥­¤É°ª»P±wªÌ±q AD ¶i®i¬° ACLF¡BACLF ªºÄY­«µ{«×

©Mµu´Á¦º¤`²v¬ÛÃö¡Cºî¤W©Ò­z¡A¸Ó¬ã¨sªí©ú¡A´`Àô RIPK3 ¥i¯à§@¬°¤@ºØ¼ç¦bªº¥Íª«¼Ð»xª«¡A¥Î©ó¿ï¾Ü±wªÌ±µ¨ü°w¹ï

RIPK1 ¤¶¾Éªº²Ó­M¦º¤`ªºÃĪ«ªvÀø¡C

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/9 ¤W¤È 10:13:18²Ä2708½g¦^À³
³o¦¸¬O¤£¬O¯uªº¡m¯T¨Ó¤F¡n?§Æ±æ­JP¦b10.17¥X®u¬ü°êÃľǮa¦~·|«á¡A¦A¦¸±Æ³X«e10¤jÃļt!

1.2022.9.22-ªYÄ£¤îµhÃÄÅçÃÒ µL¨x¬r©Ê(±Nµ²ªG´£¨Ñµ¹¦³»P¤½¥qñ­q¦³Àv¦X¬ù¤§°ê»Ú¤îµhÃļt°Ó)

2.2022.10.17­JP¦b¬ü°êÃľǮa¦~·|µoªí-«D°sºë©Ê¯×ªÕ¨x©w¶q¨x¥\¯àÀË´ú

eventscribe.net/2022/PharmSci360/fsPopup.asp?Mode=posterinfo&PosterID=528564

3.2022.10.19-ªYÄ£¯×ªÕ¨xª¢·sÃĤG´ÁÁ{§Éµ²ªG ¦b¬ü°êÃľǮa¦~·|µoªí

4.2022.10.30-ªYÄ£¤îµh·sÃĸÑÂê40¦~¨x¬r©Ê°ÝÃD °ê»Ú¤j¼t±ÂÅv¦b±æ(¦¶¸³±µ¨ü¤¤¥¡ªÀ±M³X)¡u¿ïÃD¡B¤H¤~¡B´¼¼z°]²£«OÅ@¦n¤£¦n¡B°]°È­±Ã­©w«×¡A³£¬O·sÃĤ½¥q¦¨¥\ªº¥ý¨M±ø¥ó¡v

·sÃĶ}µo_¿ïÃD

www.facebook.com/100064104724409/videos/1202540343488971/?__so__=watchlist&__rv__=video_home_www_playlist_video_list

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 08:52:57²Ä 1956 ½g¦^À³

05_·sÃĶ}µo_¿ïÃD

­J¤j¯«¦b14:15¬í°_:...½Í¨ì³Ì«á ¥L»¡±z­Ì¯à¤£¯à ³o®a.§Ú´N¶R±z­ÌªºªÑ²¼°Ú.§ë¸ê±z­ÌªºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±z­n´N¶Rcompound ±z·Q¶R[¤½¥q] §Ú­Ì¤£½æ±z....½Í¨ì³o¼Ë£²...

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/8 ¤U¤È 07:03:40²Ä2707½g¦^À³
³o2¦~¤º±µ³s¸ÕÅ祢±Ñªº3¤ä¤îµhÃÄ¡A±ÂÅvª÷«Ü¥iÆ[(辉·ç18»õ¬ü¤¸ /ACP-044¦~±ÂÅv»ù­È8.87»õ¬ü¤¸/ ¥x·LÅé6.7»õ¬ü¤¸¤îµhÃÄ)!

www.pharmavoice.com/news/pain-med-non-opioid-addiction-free-South-Rampart-Pharma/637665/

¤å¤¤´£¤Îªº¤îµhÃĪ«ACP-044¡A¤µ¦~4¤ë«Å¥¬¸ÕÅ祢±Ñ!

ACP-044¦b2020¦~±ÂÅv»ù­È(8.87 »õ¬ü¤¸):

®Ú¾Ú¥æ©ö¡AACADIA ¥H 5250 ¸U¬ü¤¸ªº»ù®æÁʶR¤F CerSci ªº©Ò¦³¬y³qªÑ¡C¦¹¥~¡A¦pªGÀò±o§å­ã¡ACerSci ªÑªF¥i¯à·|Àò

±o°ª¹F 8.87 »õ¬ü¤¸ªº¶}µo¡B°Ó·~©M¾P°â¨½µ{¸O¡A¥H¤Î²b¾P°âÃBªº¤¤µ¥­Ó¦ì¼Æ¯S³\Åv¨Ï¥Î¶O¡C

-----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/9/23 ¤U¤È 01:10:22²Ä 1420 ½g¦^À³

23»õ¬ü¤¸±ÂÅvª÷ªº·s«¬¤îµhÃÄ¡A3¤ë¦b¬ü°êFDA½²î¡A¤W¶g¤S¦b¼Ú¬wEMA½¨®!

ªvÀø°©Ãö¸`ª¢(osteoarthritis)¤SºÙ¬°°h¤Æ©ÊÃö¸`ª¢ªº²Ä1½uÃĪ«:¤AñQÓi×ô»P«DÃþ©T¾J®øª¢¤îµhÃÄ(NSAID).

2006¦~¡A辉·çªá¤F约5亿¬ü¤¸¦¬购Rinat Neuroscience¡A进¦Ó获±o¤FTanezumab¡Cþ÷来¦b2013¦~ÉO辉·ç签订¤F¤@¥÷°ª达18亿¬ü¤¸ªº协议...

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/8 ¤U¤È 06:40:27²Ä2706½g¦^À³
2022.12.1- µL¬rµLÅ}¡G·s«¬¤îµhÃĪº«e´º

¬°¤°»ò South Rampart Pharma ªº·s«¬¤À¤l¥i¯à¦¨¬°¸Ñ¨M¥þ²y¯kµh¬y¦æ¯fªºÃöÁä¡C

www.pharmavoice.com/news/pain-med-non-opioid-addiction-free-South-Rampart-Pharma/637665/

¦pªG±z¦¨¥\±N¨ä±À¦V¥«³õ¡A±z¬Æ¦Ü¥i¥H¹w´ú¸ÓÃĪ«ªº»ù­È¬O¦h¤Ö¡H

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/10/21 ¤U¤È 12:33:43²Ä 2636 ½g¦^À³

²Ä2®a¬ü°ê¶¤South Rampart Pharmaªº SRP-001¨S¦³¨x¬r©Ê¨S¦³µÇ¬r©Ê--Á{§É¸ÕÅç¦h¾¯¶q»¼¼W(MAD)¨ì4000mg(4g)???

¹w­pP1µ²ªG±N¦b 2023 ¦~²Ä¤G©u«×¤½§G¡C

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/4 ¤U¤È 05:01:34²Ä2705½g¦^À³
NASHªºµo¯f¾÷¨î¤Ó½ÆÂø¡A·sªº¬ã¨sµ²ªG¤£Â_´é²{¡AGSKªá10»õ¬ü¤¸±ÂÅvªºÃĪ«¡A¤p¹«¼Ò«¬²£¥Í¤F¤£¤@­Pªºµ²ªG¡AÁÙ¦Ûµoµo®i¬°¿ðµo©Ê¯×ªÕ¨x¡C

1. 2021.3.16 Hsd17b13 ¯Ê³´¤£¯à«OÅ@¤p¹«§K¨ü­PªÎ­D©Ê¶¼­¹·l¶Ë

www.ncbi.nlm.nih.gov/pmc/articles/PMC8627256/

2. 2022.7.16(2011¦~¿Õ¨©º¸¥Í²zÂå¾Ç¼ú±o¥DBruce Beutlerªº½×¤å)

www.nature.com/articles/s41467-022-31812-4

...³Ìªñªº¤@½g½×¤å³ø¾É¤F¤@­Ó¤£¦PªºÆ[¹îµ²ªG¡A§YHsd17b13°ò¦]ºV°£¤p¹«¦b´XºØ¯×ªÕ¨x»¤¾Éªº¶¼­¹±ø¥ó¤U¡A¦b¨x¯×ªÕÅÜ

©Ê¡B¨x·l¶Ë¡BÅÖºû¤Æ©Mª¢¯g¤è­±»P WT ¤p¹«¨S¦³®t²§!

3. 2022.1.7 (­«­n­ì³ÐªÌ:Ĭ¤å) www.ncbi.nlm.nih.gov/pmc/articles/PMC8776652/

¥O¤HÅå³Yªº¬O¡A³Ìªñ¹ï HSD17B13 °ò¦]ºV°£¤p¹«ªº¬ã¨sªí©ú¡AHSD17B13 ¯Ê¥F¯g¥¼¯à«OÅ@¨xŦ§K¨ü°ª¯×ªÕ¶¼­¹¡B¦è¤è¶¼

­¹©M°sºë¼ÉÅS¤Þ°_ªº¯×ªÕÅÜ©Ê·l¶Ë¡A³oªí©ú HSD17B13 ¯Ê¥F¯g¥i¯à¹ï¤p¹« NAFLD ¨S¦³«OÅ@§@¥Î¼Ò«¬¡C¦P¼Ë¡A¥t¤@²Õ³ø

§i»¡¡A¯Ê¥F HSD17B13 °ò¦]ªº¤p¹«¦b 9 ­Ó¤ë¤j®É¦b¥¿±`¶¼­¹¤U¦Ûµoµo®i¬°¿ðµo©Ê¯×ªÕ¨x.³o¨Ç·N·Q¤£¨ìªºµ²ªG¥Ø«e¯Ê¥F

¾÷¨î¸ÑÄÀ¡A»Ý­n¶i¤@¨B¬ã¨s¡C

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/12/3 ¤U¤È 01:47:05²Ä 2700 ½g¦^À³

GSKªº10»õ¬ü¤¸±ÂÅvª÷¡A­«­n­ì³ÐªÌ¦b2014¦~µoªíªº½×¤å©~µM¦³[±m³J]Åå³ß!

·|­û:dk10140377µoªí®É¶¡:2022/12/4 ¤U¤È 02:29:05²Ä2704½g¦^À³
¦n¹³ÁÙ¬O¦³¥X9±iªº¼Ë¤l?!¦ý¬O½Ö§Ú²q¤£¨ì¤F

¥»¶g¸É­Ó¦ì¼Æ¦^·í©`¦Ì¤á

========================

ºÃ? 2¦ì¶^¯}¤d«á¡A´X¶g¨Ó«ç»ò¤£½æ¤F???

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/4 ¤W¤È 09:15:27²Ä2703½g¦^À³
¶Ç¥XGSK©Î¦¨¬°¿ÕµØ¼ç¦b¦¬ÁʥؼÐ?

2022.11.30--GSK is a potential buyout candidate for Novartis - Intron Health

·|­û:½²ºû¤¯10143700µoªí®É¶¡:2022/12/3 ¤U¤È 04:04:35²Ä2702½g¦^À³
¦A¦^¹L¥h°Q½×¯d¨¥¬Ý¡A¦]gsk2®a¦b2018¦~´N¤wñ¦X§@¨óij¡A¨º®ÉªYÄ£ÁÙ¯u¨S¦³¬Ü¥Ø¡A¤º¤ß¥i¥HÄÀÃh¤F¡C
·|­û:½²ºû¤¯10143700µoªí®É¶¡:2022/12/3 ¤U¤È 03:28:03²Ä2701½g¦^À³
gskËß10»õ¬ü¤¸¦b­°¯×ªÕ¨x¦X§@±ÂÅv¨ºÁûÃÄ¡A¶i«×©MÀø®Ä¤ñªYÄ£ºC©M®t¡I¡H¨S§äªYÄ£ÆZ¥i±¤¡I­Yµ¹15»õ¬ü¤¸¨âÁûÃĦh¦n¡AªÑªF¤]ÅwªY¡I
·|­û:ROGER588910148151µoªí®É¶¡:2022/12/3 ¤U¤È 01:47:05²Ä2700½g¦^À³
GSKªº10»õ¬ü¤¸±ÂÅvª÷¡A­«­n­ì³ÐªÌ¦b2014¦~µoªíªº½×¤å©~µM¦³[±m³J]Åå³ß!

±m³JP values <0.01:

retinol metabolism:ARO-HSD¬O°w¹ï³o¤@¹vÂI³]­pªºRNAiÀøªk¡A¥i¥H§í¨î³o¤@°ò¦]ªí¹FªºHSD17£]13³J¥Õ(¨xŦµø¶À¾J²æ²B酶)ªº²£¥Í--->GSKªº10»õ¬ü¤¸±ÂÅvª÷!

metabolism of xenobiotics by cytochrome P450, drug metabolism--->SNP-610»PSNP-630

1. 2022.11.19 奋¤æªÌ¨¬迹 | °ò础¬ì¬ã´N¬O¦bÆÓ数¦¸¥¢败¤¤«e¦æ

m.mp.oeeee.com/a/BAAFRD000020221119741302.html

2. 2014½×¤å: www.pnas.org/doi/10.1073/pnas.1410741111

... Interestingly, a group of cytochrome P450 family proteins, such as cyp2E1, cyp4A11, and cyp2C9, was also found to be associated with the LDs and up-regulated in fatty liver, perhaps suggesting that these cytochrome P450 enzymes are involved in the development of NAFLD

...there was an enrichment in 4 KEGG pathways with P values <0.01 (i.e., retinol metabolism, metabolism of xenobiotics by cytochrome P450, drug metabolism, and linoleic acid metabolism) (SI Appendix, Table S8). In the retinol metabolism pathway, 11 enzymes involved were up-regulated in the LDs of fatty livers

------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/11/26 ¤U¤È 11:03:33²Ä 1487 ½g¦^À³

¤p¤À¤lÃĪ«»PRNAÀøªk¦a¼Æ¾Ú:

SNP-610 ALT¡BAST显µÛ¤U­°

mops.twse.com.tw/nas/STR/663420190724M001.pdf

VS

2021.11.23---GSK¯{10»õ¬ü¤¸Äâ¤âArrowhead ¶}µo«D°sºë©Ê¯×ªÕ¨xRNAiÀø(¹w¥I1.2»õ¬ü¤¸)

www.drugtimes.cn/2021/11/26/10yimeiyuangskyinjinarowheaddenashrnailiaofa/

100mg¥H¤W剂¶q组¡AALT¡BAST显µÛ¤U­°

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/3 ¤W¤È 09:48:30²Ä2699½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/11/19 ¤W¤È 09:55:09²Ä 2674 ½g¦^À³

¤j·§¬O¦~ªì¨´¤µ¡A«ùªÑ¤d±i¥H¤W¡A¨C¶g©T©w½æ¥X´X¤Q±i¡A§Ú¤£­t³d¥ôªº±À´ú¥X¨º2¤H!

----------------------------------------------------------------------------------------------------

ºÃ? 2¦ì¶^¯}¤d«á¡A´X¶g¨Ó«ç»ò¤£½æ¤F???

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/2 ¤U¤È 03:35:32²Ä2698½g¦^À³
¤@¼Ë½M¤lºN¶H(¦Û¥H¬°¬O)¡A¦p¦³¤j¤j¥h¹qªYÄ£¨DÃÒ¡A½Ð¤£§[«ü¥¿!

Cordyceplen²q´ú¬O Cordycepin + Ceplene ªº¤Æ¦Xª«???

1.­J¥®®E §Ü¯f¬r药ªü©õ¬¥韦经¥Ö§l¦¬¨î剂.pdf - 专§Q -¥d敌ûÒ(Cordycepin)

www.zhuanlichaxun.net/p-319243.html

2. 2019.6.14 Âίó¯À(Cordycepin)ªºªvÀø¼ç¤O©M¥Íª«¾ÇÀ³¥Î¥H¤Î²£Âίó¯À¯uµßªº¥NÁ¾÷¨î

www.mdpi.com/1420-3049/24/12/2231/htm

3.2021.2.12 Âίó¯À(Cordycepin)³q¹L¿E¬¡ AMP ¿E¬¡³J¥Õ¿E酶«H¸¹³q¸ô§ïµ½«D°sºë©Ê¯×ªÕ©Ê¨xª¢

aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.31749

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/2 ¤W¤È 09:20:07²Ä2697½g¦^À³
¥u¯à½M¤lºN¶H¤F!¥ÌÅS¾J¥i¼W±jCepleneªºÂíµh§@¥Î???

Ceplenitol

1. Ceplen: Histamine dihydrochloride¡]°Ó«~¦WCeplene¡^¬O¤@ºØ²ÕÓiÆQ¡A¤]¬O FDA §å­ãªº§½³¡Âíµh¬¡©Ê

¦¨¤À¡A¥Î©ó¼È®É½w¸Ñ»PÃö¸`ª¢¡B³æ¯Â©Ê­Iµh¡B·ï¶Ë¡B§á¶Ë©M©Ô¶Ë¬ÛÃöªº¦Ù¦×©MÃö¸`ªº»´·L¯kµh©M¯kµh¡A

nitol:mannitol(¥ÌÅS¾J) SNP-810½á§Î¾¯

2.2020.11.26 ¥ÌÅS¾J¼W±j­f®ü©Ô©ú(Diphenhydramine)§@¬°´À¥N§½³¡³Â¾K¾¯ªºÂíµh§@¥Î

www.ncbi.nlm.nih.gov/pmc/articles/PMC7714595/

³Ìªñ³ø¾É¥ÌÅS¾J¥i¦³®Ä¼W±j§Q¦h¥d¦]ªºÂíµh§@¥Î¡C

...¥»¬ã¨s­º¦¸ÃÒ©ú¥ÌÅS¾J¥i¼W±j­f®ü©Ô©úªºÂíµh§@¥Î¡C

·|­û:¾¾¹À©OÎN¹À«¡10150521µoªí®É¶¡:2022/12/1 ¤U¤È 09:24:00²Ä2696½g¦^À³
½Ð°Ý¦U¦ì¤j¤j¬O§_ª¾¹D³o¤T­Óµù¥U°Ó¼Ð

µù¥U¤é´Á2018-3-1 FATTIDOTE ¦r¸q¤WÀ³¸Ó¬O´î­«ÃÄ

µù¥U¤é´Á2021-10-1 Cordyceplen

µù¥U¤é´Á2021-12-1 Ceplenitol

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/1 ¤U¤È 03:30:17²Ä2695½g¦^À³
这Ïú¨u见ªº¯×ªÕ组织亚¸s¡A©Î许¯àûñ§Ú们§ó¦nªºú£ªÎ!

2021.1.7 ¼¶¤å | 陈¤åüL¡]«¢¦ò¤j学³Õ¤h¦Z¡^(2020.10.28 nature¤å³¹¾ÉŪ)

www.linkresearcher.com/theses/2c809fcd-0744-4f49-a040-53d3a1705a13

CYP2E1ªí达阳©Êªº¯×ªÕ细­M¥i¯à参ÉO调±±产热®Ä应¡C

´£¥ÜALDH1A1+CYP2E1+细­M¥i¯àªí达¬Y个®Ç¤Àªc¦]¤l来§í¨î´Ä¦â¯×ªÕ细­Mªº产热®Ä应¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³

...2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x

...µo²{¤@­Ó»P²£¼ö¦³Ãöªº°ò¦] Aldh1a1¡A¸Ó°ò¦]»P Cyp2e1 Ãö«Yºò±K¡CAldh1a1 »P Cyp2e1 ¬V¦âµ²ªG¦b¦UºØ¯×ªÕ²Õ´

¤¤§e²{¥X§¹¬üªº­«¦X¡A¶i¤@¨B¦LÃÒ¤F¥¦­ÌªºÃö«Y¨Ã¤£¤@¯ë¡C

·|­û:ROGER588910148151µoªí®É¶¡:2022/12/1 ¤U¤È 01:32:18²Ä2694½g¦^À³
Âù²¸±[(CYP2E1§í¨î?)¨Ï¤p¹«Ê^­«4©Pú£轻40%¡I

www.eurekalert.org/news-releases/744765

...¡§·í§Ú­Ì¬Ý¨ì¼Æ¾ÚÅã¥Ü¤p¹«­ÌÅé­«ÆJ´î¡A¶V¨Ó¶V½G¡A§Ú­Ì­±­±¬Ûòó¡A²ª½¤£´±¬Û«H¦Û¤vªº²´·ú¡C¡¨³o¶µ¬ã¨sªº²Ä¤@§@ªÌMichel Bernier³Õ¤h»¡¹D¡C

·|­û:½²ºû¤¯10143700µoªí®É¶¡:2022/12/1 ¤U¤È 12:36:02²Ä2693½g¦^À³
©¹©õªYÄ£6¡B8¨tÀu²§¬ãµoªí²{¡F¦b¨xŦ¸Ñ¬r¡B»Ã¯À¥­¥x¹ï§Ö³t´îªÎ¨­Åé¥NÁª«¸Ñ¨Mµ¥¡AªYÄ£¬O±j¶µ¤]¤ñ§O®a·sÃĬãµo¤½¥q¦ûÀu¶Õ¡C­Y¤½¥q¦³³W¹º´îªÎÃĬãµo¡A¬O¥þªÑªF¡B¥þ¤HÃþ¤§ºÖ¡A«D±`¤ä«ù¡I
·|­û:ROGER588910148151µoªí®É¶¡:2022/12/1 ¤W¤È 10:24:56²Ä2692½g¦^À³
±q®É¶¡¥ý«á¨Ó¬Ý¡A杨¨q伟团队·|±´¯ÁCYP2E1§ÜªÎ­D§@¥Î(¬ã¨s½×¤å±NCYP2E1¡VPPAR £\¶b©w¸q¬°ªÎ­DªvÀøªº·sªvÀø¹vÂI)¡A¥i¯à¬O¬Ý¨ì2020¦~ªºÂù²¸±[±j¤jªº§ÜªÎ­D§@¥Î©Ò±Òµo¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/11/30 ¤U¤È 10:15:00²Ä 2690 ½g¦^À³

Ê^­«4©Pú£轻40%¡I(CYP2E1 §í¨î?)

2020.05.19 www.163.com/dy/article/FCVT73P105349C3F.html

..ªA¥Î双²¸仑ªº¤p¹«们¡A¥X现ªº变¤Æ让¬ì学®a们·P¨ì·N¥~¡C尽ºÞ¤´¦b¦Y°ª¯×ªÕ­¹ª«¡A­¹¶q¤]没¦³变¤p¡A¥¦们ªºÊ^­««D¦ý没¦³¼W¥[¡A还«æ剧¤U­°¡C¤×¨ä¬O¤j剂¶q双²¸仑组ªº¤p¹«¡Aµuµu¥|©P内¡AÊ^­«³Ì¦hú£轻达40%..

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/29 ¤W¤È 10:20:26²Ä 2035 ½g¦^À³

¥N谢酶(CYP2E1)ÉO®Ö¨üÊ^(PPAR£\)¤§间¦p¦ó协§@调±±¯×ªÕ´Ä¦â¤Æ¤ÎªÎ­D发¯f鲜见报¹D¡C

杨¨q伟团队ªº½×¤å´N¬O2022.5¤ë³o½gwww.sciencedirect.com/science/article/pii/S2211383522000545

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/30 ¤U¤È 10:26:19²Ä2691½g¦^À³
Âù²¸±[[¨ã¦³±j¤jªº§ÜªÎ­D§@¥Î]¡A¤]¦³«Ü±j¤jªº°Æ§@¥ÎºÙ¬°[Âù²¸¨Ú¼Ë¤ÏÀ³]¡A¨¬¥HÅýÃļt¿³½ì¯Ê¯Ê.
·|­û:ROGER588910148151µoªí®É¶¡:2022/11/30 ¤U¤È 10:15:00²Ä2690½g¦^À³
Ê^­«4©Pú£轻40%¡I(CYP2E1 §í¨î?)

2020.05.19 www.163.com/dy/article/FCVT73P105349C3F.html

..ªA¥Î双²¸仑ªº¤p¹«们¡A¥X现ªº变¤Æ让¬ì学®a们·P¨ì·N¥~¡C尽ºÞ¤´¦b¦Y°ª¯×ªÕ­¹ª«¡A­¹¶q¤]没¦³变¤p¡A¥¦们ªºÊ^­««D¦ý没¦³¼W¥[¡A还«æ剧¤U­°¡C¤×¨ä¬O¤j剂¶q双²¸仑组ªº¤p¹«¡Aµuµu¥|©P内¡AÊ^­«³Ì¦hú£轻达40%..

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 12:12:56²Ä 2024 ½g¦^À³

..FDA §å­ãªº¥Î©óªvÀø°sºë¤¤¬rªºÃĪ«Âù²¸±[ [¨ã¦³±j¤jªº§ÜªÎ­D§@¥Î]¡A¦Ó³o¨Ã«D³q¹L¨ä¹ïîDzæ²B酶2(ALDH2)ªº§í»s§@¥Î¨Ó¹ê²{ªº¡C¦bµ²ºc¤W¡AÂù²¸±[¥i¥H¥NÁ¦¨ DDC¡ACYP2E1 §í»s¾¯¡A¦]¦¹¥i¥H¦X²z¦a±ÀÂ_Âù²¸±[ªº§@¥Î¥i¯à¬O³q¹L¨ä¥NÁª« DDC ¤¶¾Éªº CYP2E1 §í¨î¡C

----------------------------------------------------------------------------------------------

SNP¤]¸Ó±´¨s¤@¤U´îªÎ®ÄªG!

·|­û:½²ºû¤¯10143700µoªí®É¶¡:2022/11/29 ¤U¤È 02:35:22²Ä2689½g¦^À³
¦bªYÄ£°Ýµª§ä¨ìµª®×¡A2016¦~¬ü°ê¤AñQ¦w×ô³B¤è¡B«D³B¤èÀ禬40»õ¬ü¤¸¡A¦Ê¤À¤§¥|±À¤É¤µ¦~¬O50»õ¬ü¤¸¡F8¨t2ÁûÃĵL¨x¬rµÇ¬r§l¤Þ¤O¡A¥þ²y¶W¹L150»õ¬ü¤¸¡A¤À¼íª÷5¦Ê¤À¤ñºâ¡A¨CªÑÁÈ300¤¸¡F6¨tµ¥630¤G´Áµ²ªG¥X¨Ó¡A´N¬O±ÂÅv¦¨¼ô¤F¡A±N¤ñ8¨t§ó¾_¾Ù¡I¤j®aºÖ®ð°Õ¡C
·|­û:ROGER588910148151µoªí®É¶¡:2022/11/27 ¤U¤È 02:51:54²Ä2688½g¦^À³
2022¦~4¤ë¦P¦æµoªíªº¬ã¨s½×¤å[¤@­Ó¥H«e¥¼³Q»{ÃѪºMBL¾÷¨î]¡A«Ü¦n¦a¸ÑÄÀ¤FSNP-610/SNP-630¯àÅãµÛ­°§C¨xŦÅÖºû¤Æªº¾÷¨î!!! SNP-610´Á¤¤¤ÀªR:F4ªº²Õ¡AªvÀø«e«á¦³[ÅãµÛ®t²§]

1. 2022.4.¤ëwww.sciencedirect.com/science/article/pii/S2352345X22000637

§Ú­Ìªº¬ã¨sµ²ªG´¦¥Ü¤F¤@­Ó¥H«e¥¼³Q»{ÃѪº¾÷¨î¡A¨ä¤¤ MBL-HSC ¬Û¤¬§@¥Î«P¶i HSC °I¦Ñ©MÀH«áªºÅÖºû¤Æ½w¸Ñ¡A¬°»P¨xÅÖºû¤Æ¬ÛÃöªº CLD ªºªvÀøµ¦²¤´£¨Ñ¤F¨£¸Ñ¡C

³o¨Ç¼Æ¾Úªí©ú¡A¨xŦ MBL ªí¹Fªº«ì´_½w¸Ñ¤F¥Ñ©ó MBL ¯Ê¥F¤Þ°_ªº¨xÅÖºû¤Æ¶i®i¡A³o·N¨ýµÛ MBL ¦³§U©ó§ïµ½¨xÅÖºû¤Æ¶i®i¡C«ì´_¨x MBL ªí¹F´X¥G§¹¥þ®ø°£¤F¥Ñ©ó MBL ¯Ê¥¢¾É­Pªº¨xÅÖºû¤Æ¥[­«¡A´£¨Ñ¤F MBL ¦³§U©ó§ïµ½¨xÅÖºû¤ÆªºÃÒ¾Ú¡C

Á`¤§¡A§Ú­Ìªº¼Æ¾Ú´£¨Ñ¤F¥O¤H«HªAªºÃÒ¾Ú¡AÃÒ©ú MBL ¹ï©ó±±¨î¨xÅÖºû¤Æ¶iµ{¦ÜÃö­«­n

2. 2008¦~ pubmed.ncbi.nlm.nih.gov/18336595/

»P¤¤«×ÅÖºû¤Æ±wªÌ¡]F2 ´Á¡^¬Û¤ñ¡A­««×ÅÖºû¤Æ±wªÌ¡]F4 ´Á¡^»P§C¤ô¥­MBL¡]XA/XA¡BXA/YO ©M YO/YO¡^¬ÛÃöªº°ò¦]«¬Åã

µÛ­°§C¡]P = 0.04) ©M¹ï·Ó²Õ (P = 0.011)¡C

----------------------------------------------------------------------------------------------------

·|­û¡GRock00910149258 µoªí®É¶¡:2022/10/19 ¤U¤È 05:04:37²Ä 2619 ½g¦^À³

1.¨Æ¹êµo¥Í¤é:111/10/19...¤@¡BSNP-630ªvÀøªº¤p¹«ªº¨xµoª¢¡B¨x¯×ªÕÅÜ©Ê©MÅÖºû¤Æ±o¨ìÅãµÛ§ïµ½¡A¨äALT¤ô¥­¡B

ÅÖºû¤Æ¬ÛÃö¥Íª«¼Ð°O¡]§Yalpha-SMA¡BCol1a1¡BCol3a1©MTimp-1¡^§¡ÅãµÛ­°§C¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/7/3 ¤W¤È 08:30:15²Ä 2172 ½g¦^À³

F4°ò¥»ºâ¬O¥Ø«eÃĪ«¬ãµoªº¸T°Ï¡A¯e¯f¶i®i¨ì¨xµw¤Æ¤§«á¦A°fÂà¬O«D±`§xÃøªº¡A¦pªG¯à°µ¥XÀø®Ä¡A¯uªº´N¤jº¡³e¤F¡C

©Ò¥HSNP-610´Á¤¤¤ÀªR:F4ªº²Õ¡AªvÀø«e«á¦³[ÅãµÛ®t²§]---¹Ú´K¥H¨D¦Ó¥B¬Ý¨ì$$$ª÷¥ú°{°{$$$

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/27 ¤U¤È 12:18:59²Ä2687½g¦^À³
¬°¦óSNP-810½á§Î¾¯:¥ÌÅS¾J»P¤T´â½©¿}¯à¸Ñ¨M¨x¬r©Ê°ÝÃD?

©³¤Uªº¬ã¨s½×¤å»P¼v¤ù¦³µª®×!(¥ÌÅS¾J»P¤T´â½©¿}-->MBL-->§í¨îCYP2E1-->´î¤ÖAPAP¨x¬r©Ê)

1. 2019.2.1 ¥ÌÅS»EÁÞµ²¦X¾®¶°¯À(MBL)³q¹L ROS ¨Ì¿à©Ê JNK/SP1 ³q¸ô½Õ¸` CYP2E1 ªí¹F¡A±q¦Ó´î»´¹ï¤A酰®ò°ò×ô»¤¾Éªº¨x¬r©Ê

onlinelibrary.wiley.com/doi/full/10.1002/eji.201847830

MBL ¬O¤@ºØ·½¦Û¨xŦªº´`Àô¦å¼ß³J¥Õ....³o¨Ç¼Æ¾Úªí©ú MBL ¦b APAP »¤¾Éªº«æ©Ê¨x·l¶Ëªºµo¯f¾÷¨î¤¤§í¨î CYP2E1 ªí¹F¡C

2.Lectin Pathway of Complement System

www.youtube.com/watch?v=9Y0q_z2o-_c

¾®¶°¯À³~®|©l©ó¥ÌÅS¿}µ²¦X¾®¶°¯À (MBL) ©Î»P¬Y¨Ç¿}µ²¦XªºÅÖºû½¦³J¥Õ¡C¦b¸Ó³~®|¤¤¡Aµ²¦X¥ÌÅS¿}ªº¾®¶°¯Àµ²¦X¥ÌÅS¿}¡B¸²µå¿}©Î¨ä¥L¨ã¦³ 3- ©M 4-OH °ò¹Îªº¿}

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/27 ¤W¤È 11:12:21²Ä2686½g¦^À³
J&J¨S¸Ñ¶}ªº¨x¬r©Ê!

2022.8¤ë-J&J¶}µoªºµL¨x¬rTylenol(JNJ-10450232)¬ã¨s³ø§i

www.sciencedirect.com/science/article/abs/pii/S0273230022001234

JNJ-10450232 (NTM-006) ¬O¤@ºØ·sªº¤À¤l¹êÅé¡A¨äµ²ºc»P¹ï¤A酰®ò°ò×ô¬Û¦ü¡A¥i¦b°Êª«©M¤HÃþ¤¤´£¨ÑÃþ¦üªºÂíµh§@¥Î¡A¦Ó¤£·|¦bÁ{§É«e¼Ò«¬¤¤¤Þ°_»P¹ï¤A酰®ò°ò×ô¹L¶q¬ÛÃöªº¨x¬r©Ê¡C

¦h¾¯¶qµ¹ÃÄ«á¡A¶À´³¥Ö¯l©M¥þ¨­©Ê¬õ´³¬O³Ì±`¨£ªºÃĪ«¬ÛÃö¤£¨}¨Æ¥ó¡C

------------------------------------------------------------------------------------------------

¹ïSNP-810¤£ºc¦¨«Â¯Ù¡A¤è¤è­±­±¨Ó¬ÝSNP-810¬Ò³Ó¥X!

1.J&J¦b2019.10.10±NJNJ-10450232½æµ¹Neumentum¤½¥q(NTM-006)

www.thepharmaletter.com/article/neumentum-nabs-j-j-pain-molecules

2.P2¸ÕÅç°±¯d¦b2017¦~clinicaltrials.gov/ct2/show/NCT02209181?term=JNJ-10450232&draw=2&rank=1

3.³o¤äNTM-006»P¤§«e´£¹Lªº3®a¬ü°ê¶¤¦P¼Ë¬OAPAPµ²ºcÃþ¦üª«¡A±q­ìª«®Æ»P»sµ{³]³ÆÅܰʪº»s³y¦¨¥»¡A»PAPAPµ²ºcÃþ¦üª«¦s

¦³ªº¦w¥þ©ÊµS¥¼ª¾?(SNP-810½á§Î¾¯:¥ÌÅS¾J»P¤T´â½©¿}¦bÂåÃÄ·~»P­¹«~·~¤w¨Ï¥Î¼Æ¤Q¦~)

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/27 ¤W¤È 09:17:51²Ä2685½g¦^À³
¯}»õ¤F!!!

2022.11.24¥@¤W³Ì¶QÃľ¯Àò­ã¤W¥« ¤A«¬¦å¤Í¯f°ò¦]Àøªk¨C¾¯©w»ù¶W¹L1»õ¤¸¥x¹ô

FDA§å­ã¿D¬wÃļtCSL Behringªº¤A«¬¦å¤Í¯fªº°ò¦]ÀøªkHemgenix¡A³o¬O¤@ºØ¤@¦¸©Ê¿é²G¡A¦³§U±wªÌ§K©ó±`³WªvÀø¡A¦ý¬OCSL±N¨C¤@¾¯©w»ù¬°350¸U¬ü¤¸¡]¬ù1.09»õ¤¸¥x¹ô¡^¡A¦¨¬°¥@¬É¤W³Ì©ù¶QªºÃĪ«¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/8/18 ¤U¤È 12:44:04²Ä 2324 ½g¦^À³

¥k¤âÂå«O°ê½Íªk®×¤j¤M¬åÃÄ»ù¡A¥ª¤â¤Sµ¹¤F¥v¤W³Ì©ù¶QªºÃĪ«»ù280¸U¬ü¤¸!

2022.8.18 ¥v¤W³Ì©ù¶QªºÃĪ«©w»ù°ª¹F280¸U¬ü¤¸

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/25 ¤W¤È 08:23:48²Ä2684½g¦^À³
·|­û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/8/16 ¤U¤È 01:47:04²Ä 2317 ½g¦^À³

...¸zªc¯ÀÃĪ«¬O±q­°§C­¹¼¤¤Î©µ¿ð±ÆªÅ­G³¡ªº®ÄªG¨Ó¹F¦¨´îªÎªº®ÄªG¡A¦Ó SNP-610/630 ¬O´î¤Ö¯×ªÕ§Î¦¨¤ÎÂà´«¨x¯×ªÕªº¯S©ÊÅܦ¨¤£¶Ë¨x¡A¤£¬O±q¼ö¶qÄá¨ú·½ÀYµÛ¤â¡A§Ú²q®ÄªG¥i¯à¨S¦³¸zªc¯ÀÃĪ«¨ÓªºÅãµÛ´î¤ÖÅé­«¡A¦ýªÖ©w¬O¦³¨ó¦Pªº®ÄªG¡C

------------------------------------------------------------------------------------------------

GLP-1­°§C­¹¼¤´î¤Ö¼ö¶qÄá¨ú + SNP(§í¨îCyp2e1¼W¥[¼ö¶q®ø¯Ó)-->2ªÌÁpÃĪº¨ó¦P´îªÎ®ÄªG¤j·§·|«ÜÅå¤H!

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/25 ¤W¤È 08:09:47²Ä2683½g¦^À³
¯S§O¬O¡ACyp2e1¯Ê¥F¼W¥[¯à¶q®ø¯Ó!!!

---------------------------------------------------------------------------

2022.8¤ë¬ã¨s论¤å¡G细­M¦â¯ÀP450 2E1°ò¦]ºV°£©Î§í¨î³q过调节¯à¶q®ø¯Ó预¨¾°ª¯×饮­¹诱导ªºªÎ­Dwww.sciencedirect.com/science/article/abs/pii/S0006295222002544

¾÷¨î¬ã¨sªí©ú¡ACyp2e1¯Ê¥F¤£¶È¼W¥[´Ä¦â¯×ªÕ²Õ´¡]BAT¡^©M¥Ö¤U¯×ªÕ²Õ´¡]SAT¡^¤¤²£¼ö°ò¦]ªºªí¹F¡A¦Ó¥B«P¶i¨xŦ©MBAT¤¤ªº¯×ªÕ»Ä¥NÁ¡C¯S§O¬O¡ACyp2e1¯Ê¥F³q¹L¼W¥[¨xŦ¥Í¦¨ªº酰°ò¦×ÆP¦Ó¼W¥[¯à¶q®ø¯Ó¡A酰°ò¦×ÆP¥i¥H«P¶i´Ä¦â¯×ªÕ²£¼ö¨Ã¼W¥[£]-®ñ¤Æ¡C

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/25 ¤W¤È 06:08:31²Ä2682½g¦^À³
1.¦b¥»¬ã¨s¤¤ªº¤@­ÓÅå¤Hµo²{¬O CYP2E1 ¯Ê¥F·|¿E¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]....³o¨Çµo²{±N CYP2E1-PPAR £\¶b©w¸q¬° [ªÎ­Dªv

Àø] ªº·sªvÀø¹vÂI¡C

2.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v

¦¶³Í¥Áªí¥Ü...¦P®É±N¥[³t¯×ªÕ¨x·sÃÄSNP-610¶}µo¡A­º¥ý±NÂX¼W1­¿ªº¬ãµo¤H­û<--->ªÎ­DªvÀø¥«³õ¥i¯à¦b 250 »õ¦Ü 270 »õ¬ü¤¸¤§¶¡¡A¤£±´¨sªÎ­DªvÀø¤Ó¥i±¤¤F!!!

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³

1.2022.5¤ë www.sciencedirect.com/science/article/pii/S2211383522000545

³Ìªñªº¬ã¨s¶°¤¤¦b½Õ¸`«DŸ§Ý²£¼ö¥HªvÀøªÎ­D¯g...½Õ¸`²£¼ö[¯×ªÕ½ÅÅÜ]¡C³o¶µ¬ã¨sªº¤@­ÓÅå¤Hµo²{¬O CYP2E1 ¯Ê¥F·|¿E

¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡A¦ñÀHµÛ®Ö¤ß·Å«×©M¯à¶q®ø¯Óªº¼W¥[

2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x

...µo²{¤@­Ó»P²£¼ö¦³Ãöªº°ò¦] Aldh1a1¡A¸Ó°ò¦]»P Cyp2e1 Ãö«Yºò±K¡CAldh1a1 »P Cyp2e1 ¬V¦âµ²ªG¦b¦UºØ¯×ªÕ²Õ´

¤¤§e²{¥X§¹¬üªº­«¦X¡A¶i¤@¨B¦LÃÒ¤F¥¦­ÌªºÃö«Y¨Ã¤£¤@¯ë¡C

¼Æ¾Úªí©úAldh1a1 / Cyp2e1 +²Ó­Mªí¹F¤@ºØ®Ç¤Àªc¦]¤l¡A¥¦§í¨î´Ä¦â¯×ªÕ²Ó­Mªº²£¼ö¥\¯à¡C

3.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v

¥Õ¦â¯×ªÕ²Õ´¡A¦¨¤HÅ餺´X¥G³£¬O³oÃþ«¬ªº¯×ªÕ¡A¥D­n¬O°µ¬°Àx¦s¥H¨Ñ«áÄò¨Ï¥Î¡C

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 11:04:16²Ä 2018 ½g¦^À³

CYP2E1 ¯Ê¥F·|¿E¬¡¨xŦ¹L®ñ¤Æª«酶Åé¼W´Þª«¿E¬¡¨üÅé£\ (PPAR£\ )¹v°ò¦]ªºªí¹F¡A¥]¬A¦¨ÅÖºû²Ó­M¥Íªø¦]¤l (FGF) 21¡A³o¨Ç°ò¦]¦b±q¨xŦÄÀ©ñ«á¡A·|¼W±j¯×ªÕ½ÅÅÜ©M¯à¶q®ø¯Ó¡A±q¦Ó´î¤ÖªÎ­D¡C

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/6/11 ¤W¤È 09:54:26²Ä 2061 ½g¦^À³

2022.6.10

§Ú­Ì¥¿¦b¥H¤@ºØ·sªº¤è¦¡¬Ý«ÝªÎ­D¡X¡X4 ºØÂåÃĪѥi¯à·|¨ü¯q

..¾Ú´X¦ì¥«³õ¬ã¨s¤H­ûºÙ¡A2027-28 ¦~ªÎ­DªvÀø¥«³õ¥i¯à¦b 250 »õ¦Ü 270 »õ¬ü¤¸¤§¶¡

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/24 ¤U¤È 07:16:35²Ä2681½g¦^À³
Ãz¬õªºSaxendaµ½ÅÖ¹F(½G½Gµ§)¡A¨Ó¦Û¤¦³ÁNovoNordisk¿Õ©M¿Õ¼wÃÄ«~¤½¥q¬ãµo!

SNP610/630´îªÎ®ÄªG¯à¹F¨ì10%´N¦³¥«³õ¡A¤£¥Î·B¬ü¨ìGLP-1ªº20%!

-------------------------------------------------------------------------------------------------

·|­û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/8/16 ¤U¤È 01:47:04²Ä 2317 ½g¦^À³

´î­«Ãijq±`¤j¥b®³¤£¨ì«OÀIµ¹¥I¡A¨S·Q¨ì³ºµM¯à½æ³o»ò¦n¡A»á¤H¥O¤H·N¥~¡C ¬d¤F¤@¤U¡A­ì¨Ó¥xÆW¤w¸g¦³«Ü¦hÂå¥ÍÀ°·Q´îªÎªº¤H¨Ï¥Î¸zªc¯ÀÃĪ«(off lable use)¡A¥L­Ì³qºÙ½G½G°w¡A¤@¦~ªºÃĪ«¶O¥Î 8~10 ¸U¡C

Ò\«e¸pªø´¿°Ý¹L­J±Ð±Â¡ASNP-610/630 ¯à¤£¯à·í´îªÎÃĨϥΡA­J¯ºµÛ¦^»¡¤£¦æ¡C±µµÛ¤S»¡ªA¥Î SNP-610/630 ´Nºâ¦³¯×ªÕ¨x¤]¤£¦AÅܦ¨¯×ªÕ¨xª¢¡A¤£¥²´îªÎ¡C

¸zªc¯ÀÃĪ«¬O±q­°§C­¹¼¤¤Î©µ¿ð±ÆªÅ­G³¡ªº®ÄªG¨Ó¹F¦¨´îªÎªº®ÄªG¡A¦Ó SNP-610/630 ¬O´î¤Ö¯×ªÕ§Î¦¨¤ÎÂà´«¨x¯×ªÕªº¯S©ÊÅܦ¨¤£¶Ë¨x¡A¤£¬O±q¼ö¶qÄá¨ú·½ÀYµÛ¤â¡A§Ú²q®ÄªG¥i¯à¨S¦³¸zªc¯ÀÃĪ«¨ÓªºÅãµÛ´î¤ÖÅé­«¡A¦ýªÖ©w¬O¦³¨ó¦Pªº®ÄªG¡C

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/8/6 ¤U¤È 07:24:51²Ä 2305 ½g¦^À³

2021¦~¿Õ©M¿Õ¼wGLP-1ÃþÃĪ«ºâ¤W´îªÎ»â°ì¦X­p°^ÄmÀ禬¹F95»õ¬ü¤¸!

­Y¦bNASH¤]®³¨ìÃÄÃÒ¡A¿Õ©M³o¤äGLP-1ÃÄ(¿}§¿¯f+´îªÎ+NASH)°ª®pÀ禬µ´¹ï¯}200»õ¬ü¤¸¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/8/6 ¤U¤È 06:53:40²Ä 2304 ½g¦^À³

«¥ªº20»õ±o©¹¤W+17=37»õ¬ü¤¸¤F!

2022.3.8§â¿}§¿¯f药卖¦¨ú£ªÎ药¡I诺©M诺¼w2025¦~¡§发»}¡¨­n卖¨ì37亿¬ü¤¸

www.sohu.com/a/527948439_359980

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/24 ¤W¤È 10:22:06²Ä2680½g¦^À³
2022.11.24 -¡u½G½Gµ§¡v¤j¯Ê³f ¤@¤ä1000¤¸öt¨ì1¸U¤¸

«UºÙ¡u½G½Gµ§¡vªº©ö¶g¿}µ¥ÃÄ«~¤j¯Ê³f¡A¥x°Ó¤Î¶Q°ü©ê«è¶R¤£¨ìÃÄ¡A¦³ªº¶E©Ò¤§«e¦³§yÃÄ¡A²{¦b©_³f¥i©~¡A¡u­ì¥»1¤ä1000¤¸´N¶R±o¨ì¡A²{¦böt¨ì1¸U¡v¡A»ù®æ½º¦9¦Ü10­¿¡A®`¯u¥¿ªº¿}§¿¯f±wªÌªÌ®³¤£¨ìÃÄ¡A¹ê¦b¤ÓÂ÷ÃСC

--------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/8/16 ¤U¤È 04:27:24²Ä 2318 ½g¦^À³

§Ú·|¬°¡§¦n¬Ý¡¨¶R³æ´îªÎ!

¡§ÃC­È¸gÀÙ¡¨: ³o¬O¤@­Ó¬ÝÁyªº®É¥N¡A©ÎªÌ»¡¬ÝÃC­Èªº®É¥N¡C

m.21jingji.com/article/20210530/herald/fd370e54f45dfecbff7049c4877f2ec7_zaker.html

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/22 ¤W¤È 07:26:11²Ä2679½g¦^À³
[·s«¬°t¤è¡uSNP-810¡v¡A¸g°Êª«¹êÅçµo²{¡A¥i²M°£¤j¹«¡B¤p¹«±µ¨ü°ª¾¯¶qAPAP¤Þ°_ªº¨x·l¶Ë©M²§±`¯f²zµ²ªG¡A¬Æ¦Ü¦bÄá¤JÁ`¾¯¶q°ª¹F8000 mg/kg¡B¬Û·í©ó70¤½¤çªº¤HÃþªA¥Î90§J¤U¡A¤´¹F¨ì¦s¬¡¡C]

¤W­±ªº¤å¦r±Ô­z¤£©ö©ú¥ÕSNP-810»P´¶®³¯kªº¨x¬r©Ê®t²§¦³¦h¤j¡AFBªº¤ñ¸û¹Ïªí¥iÅý±z²M·¡©úÁA®t²§¦³¦h¤j!

´¶®³¯k(2g/kg)6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú VS SNP-810(8g/kg)6°¦¨ì14¤Ñ¥þ¬¡µÛ

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 09:36:59²Ä 1994 ½g¦^À³

..www.facebook.com/watch/?v=3194947797458964

³o±i¤j¹«­P¦º¾¯¶q¹ÏªíÀ³¸Ó´N¬O¥ÑGLP¹êÅç«Ç§¹¦¨ªº¸ÕÅç?

P2000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú / (S2000(SNP-810)6°¦¤j¹«¦Ü14¤Ñ¥þ¬¡µÛ.

...

P8000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1¤p®É¤º¥þ¦º /(S8000(SNP-810)1°¦¤j¹«¦b4¤p®É¦º¥h¡A5°¦¤j¹«¨ì14¤Ñ¬¡µÛ.

­J³Õ»¡¦A°µ¤@¦¸¹êÅç(S8000(SNP-810)6°¦¨ì14¤Ñ¥þ¬¡µÛ.

·|­û:ROGER588910148151µoªí®É¶¡:2022/11/21 ¤W¤È 11:29:12²Ä2678½g¦^À³
file:///C:/Users/USER/Downloads/105%E5%B9%B4%E5%BA%A6%E5%B9%B4%E5%A0%B1.pdf

±q105¦~³ø:ÄǸtªâ. 1,450±i / ÄÇ·çªl.1,450±i-->·N§Y2¤H¨S¦³°Ñ»P«á¨Óªº´X¦¸¼W¸ê!

·|­û:dk10140377µoªí®É¶¡:2022/11/21 ¤W¤È 08:28:18²Ä2677½g¦^À³
R¤j¸Ñ´b¤F ¤§«e¤@ª½²q¤£¨ì¬O½Ö¨C¶g³£¦b°½¥X¡A¤S¬Ý¤£¨ì¥Ó³ø(·Q»¡¬O¤£¬O¤jªÑªF??)

³o¼Ë¥i¥H§ä®É¶¡¦^¸É¤F

==========================================================

¤j·§¬O¦~ªì¨´¤µ¡A«ùªÑ¤d±i¥H¤W¡A¨C¶g©T©w½æ¥X´X¤Q±i¡A§Ú¤£­t³d¥ôªº±À´ú¥X¨º2¤H!

110.4.12: ÄǸtªâ. 1,450±i / ÄÇ·çªl.1,450±i

·|­û:½²ºû¤¯10143700µoªí®É¶¡:2022/11/20 ¤U¤È 12:11:22²Ä2676½g¦^À³
±qª©«e¬Ý¬ü°ê¤AñQ¦w×ô40»õ¬ü¤¸À³¥]¬A³B¤è¡B«D³B¤è¡A¤~²Å¦X¥þ²y100»õ¬ü¤¸¡F¤§«e±À¦ô¿ù»~¡A©êºp¡IªYÄ£µL¨x¬r¡BµÇ¬r¡A¬O§¹¬ü¯«ÃÄ¡I8¨t100»õ¬ü¤¸¥«¦û¡A5¦Ê¤À²v¤À¼íª÷¡A¨CªÑÁÈ200¤¸¡A¤£·Q·íªÑ¤ý³£Ãø¡Iªø®É¶¡µ¥«Ý¡A6¨t§ó¬Oæfæf¬õ¬P¡I¤j®a®¥³ß¡C
§Ú­n¦^À³¥»¸ÜÃD
·|­û:
§@ªÌ:
¬ÛÃöªÑ²¼¤½¥q¦WºÙ:ªYÄ£¥ÍÂå
¤º®e:
½Ð¥ýµn¤J­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹
°Q½×°Ï¬ÛÃö³W©w¡G
1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«Øij¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
4.¬°ÁקK®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C

¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178 ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѬÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!